Simone Charles B, Houshmand Sina, Kalbasi Anusha, Salavati Ali, Alavi Abass
Department of Radiation Oncology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Civic Center Boulevard, TRC 2 West, Philadelphia, PA 19104, USA.
Department of Radiology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
PET Clin. 2016 Jul;11(3):319-32. doi: 10.1016/j.cpet.2016.03.001. Epub 2016 Apr 6.
Fluorodeoxyglucose-PET is increasingly being integrated into multiple aspects of oncology. PET/computed tomography (PET/CT) has become especially important in radiation oncology. With the increasing use of advanced techniques like intensity-modulated radiation therapy and proton therapy, PET/CT scans have played critical roles in the target delineation of tumors for radiation oncologists delivering conformal treatment techniques. Use of PET/CT is well established in lung cancer and several other thoracic malignancies. This article details the current uses of PET/CT in thoracic radiation oncology with a focus on lung cancer and describes expected future roles of PET/CT for thoracic tumors.
氟脱氧葡萄糖正电子发射断层扫描（Fluorodeoxyglucose-PET）越来越多地融入肿瘤学的多个方面。正电子发射断层扫描/计算机断层扫描（PET/CT）在放射肿瘤学中变得尤为重要。随着调强放射治疗和质子治疗等先进技术的使用日益增加，PET/CT扫描在为采用适形治疗技术的放射肿瘤学家进行肿瘤靶区勾画方面发挥了关键作用。PET/CT在肺癌和其他几种胸部恶性肿瘤中的应用已得到充分确立。本文详细介绍了PET/CT在胸部放射肿瘤学中的当前应用，重点是肺癌，并描述了PET/CT在胸部肿瘤未来预期发挥的作用。
